9th International Congress on Pulmonary disease, Intensive Care and Tuberculosis
The 9th International Congress on Pulmonary disease, Intensive Care and Tuberculosis was held by Dr. Masih Daneshvari Medical Center at Farhikhtegan Hospital in Tehran on October 12-15, 2019.
Actoverco’s attendance at the 3rd international Razavi cardiovascular congress (Caspian and CTO)
The 3rd international Razavi cardiovascular congress was held in Razavi Hospital from 9 to 11 October 2019 for 3 days
A different meeting for cardiologists
On the occasion of World Heart Day, a one-day symposium was hosted by Actoverco Pharmaceutical Company in coordination with the World Heart Federation and accompanied by specialized cardiovascular associations in Iran and attended by more than 150 physicians and cardiologists.
Visit of neurologists and psychologists from Actoverco Pharmaceutical Factories
Actover Group, on the occasion of Doctor’s Day, hosted a group of prominent neurology and psychologist professors of Tehran on Thursday, August 22.
Actoverco’s Active participation in the 21st International Congress on Cardiovascular Updates in Milad Tower International Conference Hall
This congress started on August 20 and will continue until tomorrow, August 23.
Explanation of the manufacturer of the news-making drug “Losartan”
Following the Food and Drug Administration’s order to collect Losartan drug with Indian active ingredient from the supply level, the Iranian company “Actoverco” announced in a statement that it has issued an immediate stop order to sell Losartan drug to distribution companies and the drug collection process from the pharmacies has started.
Senior Lebanese officials visit from the Actover Group factories
Adviser of the Lebanese Minister of Health, at the head of a high-level delegation of senior officials of this ministry, while visiting the factories of Actover Pharmaceutical Group and the greatest oncology drugs production site in Iran and the region, emphasized on the expansion of Iran-Lebanon pharmaceutical cooperation.
Actoverco company announcement
According to the public relations of Actover Group, following the correspondence of the Food and Drug Administration on July 2, 2019 regarding the recall (collection) of Losartan drug of Actoverco…
Dr. Sattari’s visits from Actoverco, Actoverco’s Innovation Center launch and signing two cooperation agreements
The Vice President for Science and Technology visited the production lines and various sections of this pharmaceutical complex at the Actoverco factory.
Signing agreement of cooperation and establishment of a new innovation center in the Actoverco company
Signing agreement of cooperation for the establishment of the “Actotech Innovation Center” and the beginning of the official knowledge-based activities in the Actoverco company was held in the presence of the Vice President for Science and Technology.
Vague comments about drug monopolies
Homayoun Hashemi, the head of the Food and Drug Faction, said at the inauguration ceremony of the new Actoverco Solid Drug Production Factory : “Some existing monopolies in the field of medicine must be broken.
Reduction in the number of imported drugs with similar domestic production to 440 items
The head of Iranian Food and Drug Administration said at the opening ceremony of Actoverco’s new factory for the production of solid drugs : “This year, the issuance of production licenses by the Food and Drug Administration will be accelerated.”